KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

The Role of Precision Nutrition in Kidney Disease

Narasaki Y, Rhee CM, Li Z. The Role of Precision Nutrition in Kidney Disease. Clin J Am Soc Nephrol. 2025 Jul 1. doi: 10.2215/CJN.0000000807. Epub[...]

The Association of Antiemetics Use with Incident Chronic Kidney Disease

Kalantar DS, Takahashi R, Shen JI, Tran D, Ismail A, Pena EL, Abichequer-Beer M, Thomas F, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP, Rhee[...]

Managing Patients with Hyperchloremia

Nagami GT. Managing Patients with Hyperchloremia. Clin J Am Soc Nephrol. 2025 Jun 30. doi: 10.2215/CJN.0000000806. Epub ahead of print. PMID: 40587230.